FLUOXYMESTERONE · 5 MG · 100 TABLETAS | Fuerza Bruta. Agresividad Controlada.

Key Benefits of Fluoxymesterone Significant Increase in Strength and Explosive Power Fluoxymesterone is recognized for its ability to significantly increase strength, aggression, and explosive power . Its high androgenic activity translates to greater intensity in training and the ability to lift heavier weights. This makes it the ideal tool for performance peaks at critical moments. High Oral Potency without Water Retention Fluoxymesterone is a 17-alpha-alkylated derivative of testosterone, designed to resist hepatic degradation and offer high oral bioavailability . Unlike other androgens, it does not aromatize to estrogen, so it does not produce water retention or gynecomastia. This makes it an ideal tool for definition and pre-competition phases, where muscle sharpness and lack of subcutaneous fluid are paramount. Increased Aggression and Mental Focus Fluoxymesterone has a strong effect on the central nervous system. Users report a notable increase in aggression and mental focus during training, attributed to its effect on neural circuits regulating aggression . This provides a psychological advantage in contact sports and weightlifting . Superior Potency to Methyltestosterone Fluoxymesterone is approximately five times more potent than methyltestosterone . This superior potency allows significant androgenic effects to be achieved with lower doses. Effect on Nitrogen Retention and Protein Synthesis Fluoxymesterone produces retention of nitrogen, potassium, phosphorus, and calcium, increasing protein synthesis and reducing amino acid catabolism . This anabolic effect contributes to muscle mass preservation during periods of high intensity. Support for Definition and Vascularity By not producing water retention, fluoxymesterone contributes to a drier, more defined, and vascular appearance. This is especially beneficial in definition and pre-competition phases.

Function and Mechanism of Action of Fluoxymesterone Fluoxymesterone is a synthetic androgen derived from testosterone, acting as a potent androgen receptor (AR) agonist . Its chemical structure (9-fluoro-11β,17β-dihydroxy-17-methylandrost-4-en-3-one) confers resistance to hepatic metabolism and high oral bioavailability . Detailed Mechanism of Action: Androgen Receptor Binding: Fluoxymesterone binds to the androgen receptor with relatively low affinity compared to other androgens . However, its potent in vivo effect is attributed to its metabolic stability and the formation of active metabolites such as 5α-dihydrofluoxymesterone . The receptor-ligand complex translocates to the nucleus, dimerizes, and binds to androgen response elements (AREs) on DNA . Gene Transcription Activation: The AR-fluoxymesterone complex binding to AREs recruits coactivator proteins and modulates the transcription of target genes involved in muscle growth, protein synthesis, and nitrogen retention . This results in increased protein synthesis and retention of nitrogen, potassium, phosphorus, and calcium . Central Nervous System Modulation: Fluoxymesterone modulates neural circuits regulating aggression, through GABA, serotonin, and arginine vasopressin systems, contributing to its effect on aggression and mental focus . 11β-HSD2 Inhibition: Fluoxymesterone is a potent inhibitor of the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), responsible for inactivating glucocorticoids such as cortisol . Inhibition of this enzyme can lead to cortisol accumulation in certain tissues, contributing to effects such as hypertension and electrolyte imbalances . Absence of Aromatization: Fluoxymesterone does not aromatize to estrogen, so it lacks estrogenic effects such as water retention and gynecomastia.

How to Use Fluoxymesterone Route of Administration: Oral. Fluoxymesterone is administered as tablets for oral ingestion. Tablets should be swallowed whole with water. Dosage: Dosage should be determined by a physician according to indications and patient condition. General dosage guidelines for fluoxymesterone include: Hypogonadism (Males): 5-20 mg daily . Delayed Puberty (Males): 2.5-20 mg daily for 4-6 months . Anabolic Effects: 4-10 mg daily . Breast Carcinoma (Females): 10-40 mg daily in divided doses for ≥3 months . Frequency: Daily doses are divided into 2-4 administrations throughout the day . Treatment Duration: Depends on the type and intensity of symptoms. For performance peaks, short cycles of 2-4 weeks are recommended. Prolonged treatment without medical supervision can cause serious side effects . Storage: Store in a cool, dry place, protected from light and at controlled temperature (2-8°C). Keep out of reach of children. Important Notice: Product intended FOR HUMAN USE under medical supervision. Fluoxymesterone is a prescription medication and its use must be supervised by a physician. It is classified as a Schedule III controlled substance in the United States. Contraindications include prostate carcinoma, male breast cancer, and severe hepatic disease . Serious side effects include liver damage, cholesterol changes, virilization in women, and psychiatric effects

Ingredients of Fluoxymesterone Active Ingredient: Fluoxymesterone (9-fluoro-11β,17β-dihydroxy-17-methylandrost-4-en-3-one): A synthetic androgen derived from testosterone, recognized for its ability to significantly increase strength and aggression . Acts as an androgen receptor agonist and is approximately 5 times more potent than methyltestosterone . Molecular formula: C₂₀H₂₉FO₃. Molecular weight: 336.44 g/mol . CAS: 76-43-7 . Excipients: Each 5 mg tablet contains the following excipients (according to standard fluoxymesterone formulations): Lactose monohydrate: Used as an excipient and bulking agent. Microcrystalline cellulose: Used as a bulking agent and disintegrant. Corn starch: Used as a disintegrant and bulking agent. Magnesium stearate: Used as a lubricant. Colloidal anhydrous silica: Used as a flow agent. Note: Specific excipients may vary by manufacturer. Consult the product leaflet for the complete list of excipients. Note for Users: This product is a pharmaceutical-grade medication manufactured under strict quality control standards (GMP) by Kinetix Pharma, in the Czech Republic. Each package contains 100 tablets of 5 mg each. Fluoxymesterone is classified as a Schedule III controlled substance in the United States.

Onset Time &amp;amp;amp;amp; Expected Results of Fluoxymesterone Onset of Action (Hours to Days): Fluoxymesterone begins acting within the first hours after oral administration. Effects on strength, aggression, and mental focus are observed within the first days of treatment. The half-life of fluoxymesterone is approximately 9.2 to 10 hours, allowing rapid onset of action . Measurable Benefits (1-2 Weeks): The first measurable changes in strength, aggression, and body composition begin to be visible within the first 1-2 weeks of consistent use. Users report a notable increase in training intensity and the ability to lift heavier loads. Full Effect (2-4 Weeks): For maximum strength increase and complete body composition improvement, the full effect often requires 2-4 weeks of consistent use according to the research protocol. Cycle duration for performance peaks is typically 2-4 weeks. Factors Influencing Results: The speed and magnitude of results depend on dose administered, administration frequency, adherence to the treatment protocol, the patient&amp;amp;amp;#039;s baseline condition, nutrition quality, and training type.

Clinical Research &amp;amp;amp;amp; 3rd Party Test Results of Fluoxymesterone Scientific evidence on fluoxymesterone comes from decades of medical use and clinical studies. Clinical Evidence in Humans: Relative Potency: Fluoxymesterone is approximately 5 times more potent than methyltestosterone in clinical practice . In animal studies, it has been reported to be up to 10 times more potent . Anabolic Effects: Fluoxymesterone produces retention of nitrogen, potassium, phosphorus, and calcium, increasing protein synthesis and reducing amino acid catabolism . Absence of Estrogenic Effects: By not aromatizing to estrogen, it does not produce water retention or gynecomastia. Sodium retention is minimal, so edema is not usually a complication in clinical use . Central Nervous System Effects: Fluoxymesterone modulates neural circuits regulating aggression, through GABA, serotonin, and arginine vasopressin systems . Preclinical Evidence: 11β-HSD2 Inhibition: Fluoxymesterone is a potent inhibitor of the enzyme 11β-hydroxysteroid dehydrogenase type 2 with an IC₅₀ of 60-100 nM . Metabolism: Fluoxymesterone is metabolized in the liver through several pathways, including 6β-hydroxylation, 5α/5β-reduction, and 11-oxidation . The formation of 5α-dihydrofluoxymesterone is an important determinant of its in vivo potency . Safety Considerations: Contraindications: Prostate carcinoma, male breast cancer, and severe hepatic disease . Serious Side Effects: Liver damage (including hepatocellular neoplasms, peliosis hepatis, and hepatic coma), cholesterol changes, virilization in women, psychiatric effects (depression, anxiety), and libido changes . Regulatory Status: Classified as a Schedule III controlled substance in the United States. Kinetix Pharma Quality Standards: Pharmaceutical Grade: Pharmaceutical-grade medication for human use. Manufacturing: Manufactured in the Czech Republic under strict GMP standards by Kinetix Pharma. Quality Control: Each batch is subjected to quality control testing to ensure purity and potency.

Product Details

FLUOXYMESTERONE · 5 MG · 100 TABLETAS | Fuerza Bruta. Agresividad Controlada.

FLUOXYMESTERONE · 5 MG · 100 TABLETAS | Fuerza Bruta. Agresividad Controlada.

Build Your Stack

Frequently Asked Questions